Novice Trade: UnitedHealth on 'Medicare for All' Weakness

Insurance companies would have their claws in any potential new healthcare law so deep, the law will have slash marks on it.

Be Careful With Healthcare Stocks Here

Especially when healthcare CEOs discus political issues with analysts and reporters.

Bank Earnings: Here's What We Know So Far

Here's your very own bank earnings 'cheat sheet.'

Disney and the Battle of Fundamental vs. Technical

At the very least, the valuation may be morphing from traditional old school media to a blend of media and tech.

Market Eats Up Pinterest and Zoom IPOs and Yawns at Mueller Report

The current picture of mixed action for a market still very close to its all-time highs is something to watch.

Canopy Growth Now Has to be Considered the Leader in the Canadian Cannabis Space

CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.

Jim Cramer: Zoom, Pinterest and the Irrational Exuberance of This Market

These stocks are too hot. There's just not enough money chasing hotness.

IPO Investors Should Take Note of Pinterest's Dual Class Share Structure

Pinterest isn't exactly bringing the power to the people.

10 Speculative Stock Plays in the Biotech Sector

For investors interested in biotech, there's a lot to choose from, with options ranging from startups with potentially blockbuster new treatments to companies those that have been around the block a few times.

Procter & Gamble or Kimberly-Clark? Why One Dividend Aristocrat Has the Edge

The advantage goes to P&G as the larger of the two behemoths in consumer staples has been posting stronger results of late.